TrialJournal for immunotherapy of cancer2024

Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214.

Charlene M Mantia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.